Mexico Breast Pump Market Report

Mexico Breast Pump Market Executive Summary

The Mexico Breast Pump Market is at around $44.1 Mn in 2023 and is projected to reach $79.8 Mn in 2030, exhibiting a CAGR of 8.85% during the forecast period.

A breast pump is a mechanical device that lactating women use to extract milk from their breasts. They are available in two forms; they can be manual devices powered by hand or foot movements or automatic devices powered by electricity. Breast pumps are available in a variety of styles to meet the demands of moms. Hand-operated manual pumps are lightweight and silent, making them ideal for sporadic usage. Electric pumps are often used on a regular basis because of their higher efficiency and ability to run on mains or batteries. There are several uses for breast pumps. Many parents use them to continue breastfeeding after they return to work. They express their milk at work, which is later bottle-fed to their child by a caregiver. A breast pump may be also used to address a range of challenges parents may encounter during breast feeding, including difficulties latching, separation from an infant in intensive care, to feed an infant who cannot extract sufficient milk itself from the breast, to avoid passing medication through breast milk to the baby, or to relieve engorgement, which is a painful condition whereby the breasts are overfull.

The Mexico Breast Pump Market is driven by significant factors such as the emerging healthcare infrastructure, growing consumer awareness, and rising disposable incomes. However, high cost, lack of insurance coverage, and stigma and embarrassment restrict the growth and potential of the market.

The major players of the Mexico Breast Pump Market are Imani, Ardo, Ameda, Avent, and Evenflo, among others.

Market Dynamics

Market Growth Drivers

Emerging Healthcare Infrastructure: In Mexico, advancements in healthcare are driving significant growth in the breast pump market. As the country's healthcare system advances with upgrades in infrastructure, technology, and maternal care, there is a stronger focus on supporting breastfeeding and maternal health. Enhanced healthcare services and the introduction of modern medical technologies are raising awareness and improving the availability of breastfeeding aids, such as advanced breast pumps. Public health initiatives, increased maternal education, and better healthcare facilities are leading to higher adoption rates of breast pumps among new mothers. This intensified focus on maternal and infant health, coupled with improved access to healthcare products, is propelling the demand for breast pumps and stimulating market growth in Mexico.

Growing consumer awareness: One of the key factors driving the breast pump market’s expansion is the growing awareness among consumers. More mothers are being encouraged to use breast pumps due to more easily accessible information from healthcare professionals, websites, and social media on the advantages of nursing and the ease of using a breast pump. Furthermore, the current need for flexible parenting and workplace assistance for nursing moms has led to a rise in the usage of breast pumps, which in turn has propelled market development.

Rising disposable incomes: As disposable incomes rise, households are better able to invest in high-quality healthcare products, which is a major driving force behind the breast pump market. Families are becoming more able to afford more sophisticated breast pump devices that offer more comfort, convenience, and efficiency. Because of this increasing demand, producers are compelled to develop and broaden their product offerings, which propels market expansion.

Market Restraints

High Cost: The expensive sophisticated breast pumps impede the market's ability to develop. Even with advantages like hands-free operation, cutting-edge technology, and increased efficiency, cost prohibits budget-constrained consumers from its usage. This is especially important in rural areas where breastfeeding equipment reimbursements from healthcare providers are few. As a result, a large number of potential customers are lost, which limits market expansion.

Lack of Insurance Coverage: Breast pumps are less accessible and affordable for a large proportion of the population in Mexico, where many medical costs are paid for out of pocket. This cost barrier frequently discourages potential customers from purchasing these necessary products, especially from lower-class households. Without more insurance options, Mexico’s breast pump sector is unable to grow to its full potential.

Stigma and Embarrassment: The expansion of the breast pump market is impeded by the shame and embarrassment attached to using breast pumps. Some women are discouraged from using breast pumps due to social and cultural views, especially in public or professional situations. Using a breast pump might lead to pain due to the pump’s exposure, worries about being judged, or a lack of support from society and employers. These cultural beliefs prevent wider acceptance and adoption, which restrict market expansion.

Regulatory Landscape and Reimbursement Scenario

In Mexico, the Federal Commission for Protection against Health Risks (COFEPRIS or Comisión Federal para la Protección contra Riesgos Sanitarios) is a regulatory body of the Mexican Government; a decentralized organ of the Mexican Secretariat of Health. Among the many health-related issues it regulates in Mexico are pharmaceuticals, food safety, medical devices, organ transplants, and environmental preservation. COFEPRIS is in charge of the entire drug approval process, from the initial application to the post-market surveillance (PMS) stage, including supply and demand, advertising, commercialization, imports and exports, distribution, manufacturing, and supply.

Mexico’s pharmaceutical industry is thriving and expanding, and thus strict laws are in place to guarantee the security and effectiveness of medications made available to Mexican residents. Pharmaceutical companies seeking to sell their medications in Mexico must understand the procedure thoroughly for getting approval. The overall approval includes an extensive evaluation by COFEPRIS, accompanied by facility inspection to ensure GMP compliance. There are three different pathways for registering medicinal product with COFEPRIS. The New Drug Registration is the pathway applicable for new chemical entities that have not previously marketed anywhere in the world. Next, is the Generic Drug Registration for drugs that are similar to the already-marketed reference drugs. Lasty, Biosimilar Registration is applicable to the biological products that are similar to the approved reference biological product.

The healthcare reimbursement system in Mexico is characterized by a complex interplay between public and private sectors. For the public sector, the social security institutions are the main provider of public health insurance. Workers in the formal sector and their dependents are covered by the Instituto Mexicano del Seguro Social (IMSS). Government employees and their families are covered by the Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado (ISSSTE). To supplement public plans with extra coverage, many Mexicans opt to buy private health insurance which provides access to a greater variety of healthcare providers, such as private hospitals and specialists. The healthcare reimbursement scheme in Mexico is gradually evolving. Although many people have a safety net in public services, there are still large differences. In the future, there may be initiatives to increase public-private partnership, achieve universal coverage, and use technology to improve healthcare affordability and accessibility for all.

Competitive Landscape

Key Players

Here are some of the major key players in the Mexico Breast Pump Market:

• Imani
• Ardo
• Ameda
• Avent
• Evenflo
• Medela AG
• Philips Avent
• Elvie
• Freemie
• Willow